Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction

NCT00245271 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Anterior Cruciate Ligament Reconstruction

Interventions

DRUG: OMS103HP
DRUG: Vehicle

Sponsor

Omeros Corporation